Display options
Cite
Le M, Berman-Rosa M, Ghazawi FM, et al. Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis. Front Med (Lausanne). 2021;8:682547doi: 10.3389/fmed.2021.682547.
Le, M., Berman-Rosa, M., Ghazawi, F. M., Bourcier, M., Fiorillo, L., Gooderham, M., Guenther, L., Hanna, S., Hong, H. C., Landells, I., Lansang, P., Marcoux, D., Wiseman, M. C., Yeung, J., Lynde, C., & Litvinov, I. V. (2021). Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis. Frontiers in medicine, 8682547. https://doi.org/10.3389/fmed.2021.682547
Le, Michelle, et al. "Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis." Frontiers in medicine vol. 8 (2021): 682547. doi: https://doi.org/10.3389/fmed.2021.682547
Le M, Berman-Rosa M, Ghazawi FM, Bourcier M, Fiorillo L, Gooderham M, Guenther L, Hanna S, Hong HC, Landells I, Lansang P, Marcoux D, Wiseman MC, Yeung J, Lynde C, Litvinov IV. Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis. Front Med (Lausanne). 2021 Sep 01;8:682547. doi: 10.3389/fmed.2021.682547. eCollection 2021. PMID: 34540860; PMCID: PMC8440866.
Copy Download .nbib Format: NLM
Share it on

Front Med (Lausanne). 2021 Sep 01;8:682547. doi: 10.3389/fmed.2021.682547. eCollection 2021.

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.

Frontiers in medicine

Michelle Le, Melissa Berman-Rosa, Feras M Ghazawi, Marc Bourcier, Loretta Fiorillo, Melinda Gooderham, Lyn Guenther, Sameh Hanna, H Chih-Ho Hong, Ian Landells, Perla Lansang, Danielle Marcoux, Marni C Wiseman, Jensen Yeung, Charles Lynde, Ivan V Litvinov

Affiliations

  1. Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.
  2. Division of Dermatology, University of Ottawa, Ottawa, ON, Canada.
  3. Faculty of Medicine, University of Sherbrooke, Sherbrooke, QC, Canada.
  4. Division of Pediatric Dermatology, University of Alberta, Edmonton, AB, Canada.
  5. SKiN Centre for Dermatology, Probity Medical Research, and Queens University, Peterborough, ON, Canada.
  6. Division of Dermatology, University of Western Ontario, London, ON, Canada.
  7. Dermatology on Bloor, Toronto, ON, Canada.
  8. Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, BC, Canada.
  9. Division of Dermatology, Memorial University of Newfoundland, St. John's, NL, Canada.
  10. Division of Dermatology, University of Toronto, Toronto, ON, Canada.
  11. Division of Pediatric Dermatology, University of Montreal, Montreal, QC, Canada.
  12. Section of Dermatology, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada.
  13. Probity Medical Research, Waterloo, ON, Canada.

PMID: 34540860 PMCID: PMC8440866 DOI: 10.3389/fmed.2021.682547

[No abstract available.]

Copyright © 2021 Le, Berman-Rosa, Ghazawi, Bourcier, Fiorillo, Gooderham, Guenther, Hanna, Hong, Landells, Lansang, Marcoux, Wiseman, Yeung, Lynde and Litvinov.

Keywords: JAK inhibitor; abrocitinib; atopic dermatitis; baricitinib; eczema; gusacitinib; janus kinase; upadacitinib

Conflict of interest statement

MB an advisory board member and speaker for AbbVie, Amgen, Leo Pharma, and Janssen; a speaker for Astellas and Merck; and an investigator for AbbVie, Astellas, Amgen, Leo Pharma, Novartis, Janssen, Su

References

  1. Pediatrics. 2012 Apr;129(4):e1072-5 - PubMed
  2. J Clin Lipidol. 2017 Sep - Oct;11(5):1243-1256 - PubMed
  3. J Am Acad Dermatol. 2020 Apr;82(4):1023-1024 - PubMed
  4. Arthritis Res Ther. 2019 Apr 5;21(1):89 - PubMed
  5. Adv Exp Med Biol. 2017;1027:47-55 - PubMed
  6. Lancet. 2021 Jun 5;397(10290):2169-2181 - PubMed
  7. Arthritis Rheumatol. 2019 Nov;71(11):1788-1800 - PubMed
  8. JAMA Dermatol. 2020 Aug 1;156(8):863-873 - PubMed
  9. Ann Rheum Dis. 2018 Jul;77(7):988-995 - PubMed
  10. J Am Acad Dermatol. 2019 Apr;80(4):913-921.e9 - PubMed
  11. Immunol Rev. 2009 Mar;228(1):273-87 - PubMed
  12. J Am Acad Dermatol. 2021 Feb;84(2):479-485 - PubMed
  13. J Allergy Clin Immunol. 2019 Jan;143(1):135-141 - PubMed
  14. Front Immunol. 2019 Dec 03;10:2847 - PubMed
  15. PLoS Med. 2009 Jul 21;6(7):e1000097 - PubMed
  16. J Allergy Clin Immunol. 2018 Oct;142(4):1121-1130.e7 - PubMed
  17. J Immunol. 2010 May 1;184(9):5298-307 - PubMed
  18. PLoS Genet. 2017 Mar 8;13(3):e1006659 - PubMed
  19. N Engl J Med. 2021 Mar 25;384(12):1101-1112 - PubMed
  20. Br J Dermatol. 2018 Jul;179(1):54-62 - PubMed
  21. Mil Med Res. 2020 Feb 29;7(1):7 - PubMed
  22. Pharmacotherapy. 2020 Aug;40(8):843-856 - PubMed
  23. Gastroenterology. 2020 May;158(6):1554-1573.e12 - PubMed
  24. J Allergy Clin Immunol. 2017 Apr;139(4S):S65-S76 - PubMed
  25. Immunology. 2019 Dec;158(4):281-286 - PubMed
  26. Lancet. 2021 Jun 5;397(10290):2151-2168 - PubMed
  27. Allergy Asthma Proc. 2012 May-Jun;33(3):227-34 - PubMed
  28. Br J Dermatol. 2019 Oct;181(4):733-742 - PubMed
  29. N Engl J Med. 2016 Dec 15;375(24):2335-2348 - PubMed
  30. Br J Dermatol. 2020 Aug;183(2):242-255 - PubMed
  31. Lancet. 2019 Dec 7;394(10214):2108-2117 - PubMed
  32. J Allergy Clin Immunol. 2001 May;107(5):871-7 - PubMed
  33. Gastroenterology. 2020 Jun;158(8):2139-2149.e14 - PubMed
  34. J Invest Dermatol. 2017 Jan;137(1):26-30 - PubMed
  35. Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i34-i42 - PubMed
  36. Rheum Dis Clin North Am. 2017 Feb;43(1):79-93 - PubMed
  37. BMJ. 2019 Aug 28;366:l4898 - PubMed
  38. J Am Acad Dermatol. 2018 May;78(5):863-871.e11 - PubMed
  39. J Cutan Med Surg. 2019 Sep/Oct;23(5):551-552 - PubMed
  40. J Am Acad Dermatol. 2014 Dec;71(6):1218-33 - PubMed
  41. Lancet. 2016 Mar 12;387(10023):1109-1122 - PubMed
  42. Annu Rev Med. 2015;66:311-28 - PubMed
  43. J Allergy Clin Immunol. 2015 Sep;136(3):667-677.e7 - PubMed
  44. Can Pharm J (Ott). 2017 May 30;150(5):285-297 - PubMed
  45. Drug Saf. 2020 Sep;43(9):831-833 - PubMed
  46. Lipids Health Dis. 2019 Feb 18;18(1):54 - PubMed
  47. Br J Dermatol. 2020 Feb;182(2):418-426 - PubMed
  48. Allergy Asthma Immunol Res. 2016 May;8(3):181-90 - PubMed
  49. J Cutan Med Surg. 2021 May-Jun;25(3):315-328 - PubMed
  50. Lancet. 2020 Jul 25;396(10246):255-266 - PubMed
  51. J Am Acad Dermatol. 2016 May;74(5):841-50 - PubMed
  52. N Engl J Med. 2017 Oct 19;377(16):1525-1536 - PubMed
  53. JAMA Dermatol. 2020 Dec 1;156(12):1333-1343 - PubMed
  54. Clin Rheumatol. 2020 Feb;39(2):613-614 - PubMed
  55. Int J Dermatol. 2020 Feb;59(2):253-256 - PubMed
  56. J Allergy Clin Immunol. 2020 Mar;145(3):877-884 - PubMed
  57. JAMA Dermatol. 2019 Dec 1;155(12):1371-1379 - PubMed
  58. J Cutan Med Surg. 2017 Jan/Feb;21(1):31-39 - PubMed

Publication Types